Melanie A. Hullings

发表

Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases

P. Febbo, R. Grossman, H. Tseng, 2020, Clinical pharmacology and therapeutics.

Chimeric antigen receptor (CAR+) modified T cells targeting prostate specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC).

H. Scher, Jason S. Lewis, H. Schöder, 2013 .

Clinical Utility of the Nuclear-localized AR-V7 Biomarker in Circulating Tumor Cells in Improving Physician Treatment Choice in Castration-resistant Prostate Cancer.

H. Scher, Melanie A Hullings, R. Graf, 2020, European urology.

Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade

P. Kantoff, N. Socci, B. Taylor, 2019, JAMA oncology.

Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive Prostate Cancer

P. Kantoff, N. Schultz, M. Morris, 2020, Clinical Cancer Research.

HDAC8 mutations in Cornelia de Lange Syndrome affect the cohesin acetylation cycle

Gabriele Gillessen-Kaesbach, Ryuichiro Nakato, Katsuhiko Shirahige, 2012, Nature.

Loss-of-function HDAC8 mutations cause a phenotypic spectrum of Cornelia de Lange syndrome-like features, ocular hypertelorism, large fontanelle and X-linked inheritance.

I. Krantz, H. Hakonarson, E. Roeder, 2014, Human molecular genetics.

Application of Information Technology to Clinical Trial Evaluation and Enrollment: A Review.

D. Gerber, Helen Mayo, Melanie A Hullings, 2021, JAMA oncology.

Isolated NIBPL missense mutations that cause Cornelia de Lange syndrome alter MAU2 interaction

I. Krantz, R. Hennekam, M. Deardorff, 2011, European Journal of Human Genetics.

NIPBL rearrangements in Cornelia de Lange syndrome: evidence for replicative mechanism and genotype–phenotype correlation

I. Krantz, J. Lupski, D. Pehlivan, 2012, Genetics in Medicine.

A Phase I/Ib Trial of PD 0332991 (Palbociclib) and T-DM1 in HER2-Positive Advanced Breast Cancer After Trastuzumab and Taxane Therapy.

K. Batra, B. Haley, A. Frankel, 2021, Clinical breast cancer.

Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer

M. Gonen, H. Scher, Yipeng Wang, 2020, Cancer Research.

Chimeric antigen receptor (CAR+) modified T cells targeting prostate-specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC).

H. Scher, Jason S. Lewis, M. Sadelain, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.